EcoDrugPlus

Histone Deacetylase 11

Ensembl ID : ENSDNOG00000018976
Gene Symbol: HDAC11
2 Cross references
190 Possible Orthologues:

Histone Deacetylase 2

Ensembl ID : ENSDNOG00000035453
Gene Symbol: HDAC2
2 Cross references
204 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSDNOG00000008318
Gene Symbol: HDAC3
2 Cross references
156 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSDNOG00000004946
Gene Symbol: HDAC4
2 Cross references
265 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSDNOG00000038658
Gene Symbol: HDAC5
4 Cross references
194 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSDNOG00000002754
Gene Symbol: HDAC6
2 Cross references
183 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSDNOG00000018384
Gene Symbol: HDAC7
4 Cross references
263 Possible Orthologues:

Histone Deacetylase 9

Ensembl ID : ENSDNOG00000049792
Gene Symbol: HDAC9
2 Cross references
233 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSDNOG00000023640
Gene Symbol: HCN4
4 Cross references
288 Possible Orthologues:

Hypocretin Receptor 1

Ensembl ID : ENSDNOG00000010273
Gene Symbol: HCRTR1
2 Cross references
95 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSDNOG00000014673
Gene Symbol: HCRTR2
2 Cross references
199 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1-Like

Ensembl ID : ENSDNOG00000002167
Gene Symbol: LOC101447628
3 Cross references
97 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).